{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:27:03Z","timestamp":1792081623122,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,3,1]],"date-time":"2007-03-01T00:00:00Z","timestamp":1172707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2007,3]]},"DOI":"10.1124\/jpet.106.113357","type":"journal-article","created":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T01:50:49Z","timestamp":1164937849000},"page":"1023-1029","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["5-Hydroxytryptamine2C Receptor Contribution to m-Chlorophenylpiperazine and N-Methyl-\u03b2-carboline-3-carboxamide-Induced Anxiety-Like Behavior and Limbic Brain Activation"],"prefix":"10.1016","volume":"320","author":[{"given":"Elizabeth A.","family":"Hackler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg H.","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul J.","family":"Gresch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saikat","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel Y.","family":"Deutch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm J.","family":"Avison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Gore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Sanders-Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.106.113357_bib1","doi-asserted-by":"crossref","unstructured":"Anderson IM, Clark L, Elliott R, Kulkarni B, Williams SR, and Deakin JF (2002) 5-HT(2C) receptor activation by m-chlorophenylpiperazine detected in humans with fMRI. Neuroreport 13: 1547-1551.","DOI":"10.1097\/00001756-200208270-00012"},{"key":"10.1124\/jpet.106.113357_bib2","doi-asserted-by":"crossref","unstructured":"Bagdy G, Graf M, Anheuer ZE, Modos EA, and Kantor S (2001) Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. Int J Neuropsychopharmacol 4: 399-408.","DOI":"10.1017\/S1461145701002632"},{"key":"10.1124\/jpet.106.113357_bib3","doi-asserted-by":"crossref","unstructured":"Bateson AN (2002) Basic pharmacologic mechanisms involved in benzodiazepine tolerance and withdrawal. Curr Pharm Des 8: 5-21.","DOI":"10.2174\/1381612023396681"},{"key":"10.1124\/jpet.106.113357_bib4","doi-asserted-by":"crossref","unstructured":"Benjamin D, Lal H, and Meyerson LR (1990) The effects of 5-HT1B characterizing agents in the mouse elevated plus-maze. Life Sci 47: 195-203.","DOI":"10.1016\/0024-3205(90)90320-Q"},{"key":"10.1124\/jpet.106.113357_bib5","doi-asserted-by":"crossref","unstructured":"Bilkei-Gorzo A, Gyertyan I, and Levay G (1998) m CPP-induced anxiety in the light-dark box in rats\u2013a new method for screening anxiolytic activity. Psychopharmacology (Berl) 136: 291-298.","DOI":"10.1007\/s002130050568"},{"key":"10.1124\/jpet.106.113357_bib6","doi-asserted-by":"crossref","unstructured":"Campbell BM and Merchant KM (2003) Serotonin 2C receptors within the basolateral amygdala induce acute fear-like responses in an open-field environment. Brain Res 993: 1-9.","DOI":"10.1016\/S0006-8993(03)03384-5"},{"key":"10.1124\/jpet.106.113357_bib7","doi-asserted-by":"crossref","unstructured":"Charney DS, Woods SW, Goodman WK, Heninger GR (1987) Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects. Psychopharmacology (Berl) 92: 14-24.","DOI":"10.1007\/BF00215473"},{"key":"10.1124\/jpet.106.113357_bib8","doi-asserted-by":"crossref","unstructured":"Chen YI, Choi JK, and Jenkins BG (2005) Mapping interactions between dopamine and adenosine A2a receptors using pharmacologic MRI. Synapse 55: 80-88.","DOI":"10.1002\/syn.20091"},{"key":"10.1124\/jpet.106.113357_bib9","doi-asserted-by":"crossref","unstructured":"de Mello Cruz AP, Pinheiro G, Alves SH, Ferreira G, Mendes M, Faria L, Macedo CE, Motta V, Landeira-Fernandez J (2005) Behavioral effects of systemically administered MK-212 are prevented by ritanserin microinfusion into the basolateral amygdala of rats exposed to the elevated plus-maze. Psychopharmacology (Berl) 182: 345-354.","DOI":"10.1007\/s00213-005-0108-2"},{"key":"10.1124\/jpet.106.113357_bib10","doi-asserted-by":"crossref","unstructured":"Dixon AL, Prior M, Morris PM, Shah YB, Joseph MH, and Young AM (2005) Dopamine antagonist modulation of amphetamine response as detected using pharmacological MRI. Neuropharmacology 48: 236-245.","DOI":"10.1016\/j.neuropharm.2004.10.006"},{"key":"10.1124\/jpet.106.113357_bib11","doi-asserted-by":"crossref","unstructured":"Dorow R, Horowski R, Paschelke G, and Amin M (1983) Severe anxiety induced by FG 7142, a beta-carboline ligand for benzodiazepine receptors. Lancet 2: 98-99.","DOI":"10.1016\/S0140-6736(83)90076-4"},{"key":"10.1124\/jpet.106.113357_bib12","doi-asserted-by":"crossref","unstructured":"Dudley RE, Nelson SR, and Samson F (1982) Influence of chloralose on brain regional glucose utilization. Brain Res 233: 173-180.","DOI":"10.1016\/0006-8993(82)90938-6"},{"key":"10.1124\/jpet.106.113357_bib13","doi-asserted-by":"crossref","unstructured":"Duncan GE, Miyamoto S, Leipzig JN, and Lieberman JA (2000) Comparison of the effects of clozapine, risperidone, and olanzapine on ketamine-induced alterations in regional brain metabolism. J Pharmacol Exp Ther 293: 8-14.","DOI":"10.1016\/S0022-3565(24)39197-9"},{"key":"10.1124\/jpet.106.113357_bib14","doi-asserted-by":"crossref","unstructured":"Febo M, Segarra AC, Nair G, Schmidt K, Duong TQ, and Ferris CF (2005) The neural consequences of repeated cocaine exposure revealed by functional MRI in awake rats. Neuropsychopharmacology 30: 936-943.","DOI":"10.1038\/sj.npp.1300653"},{"key":"10.1124\/jpet.106.113357_bib15","doi-asserted-by":"crossref","unstructured":"Feng J, Cai X, Zhao J, and Yan Z (2001) Serotonin receptors modulate GABA(A) receptor channels through activation of anchored protein kinase C in prefrontal cortical neurons. J Neurosci 21: 6502-6511.","DOI":"10.1523\/JNEUROSCI.21-17-06502.2001"},{"key":"10.1124\/jpet.106.113357_bib16","doi-asserted-by":"crossref","unstructured":"Gatch MB (2003) Discriminative stimulus effects of m-chlorophenylpiperazine as a model of the role of serotonin receptors in anxiety. Life Sci 73: 1347-1367.","DOI":"10.1016\/S0024-3205(03)00422-3"},{"key":"10.1124\/jpet.106.113357_bib17","doi-asserted-by":"crossref","unstructured":"Griebel G, Perrault G, and Sanger DJ (1997) A comparative study of the effects of selective and non-selective 5-HT2 receptor subtype antagonists in rat and mouse models of anxiety. Neuropharmacology 36: 793-802.","DOI":"10.1016\/S0028-3908(97)00034-8"},{"key":"10.1124\/jpet.106.113357_bib18","doi-asserted-by":"crossref","unstructured":"Hajnal JV, Myers R, Oatridge A, Schwieso JE, Young IR, and Bydder GM (1994) Artifacts due to stimulus correlated motion in functional imaging of the brain. Magn Reson Med 31: 283-291.","DOI":"10.1002\/mrm.1910310307"},{"key":"10.1124\/jpet.106.113357_bib19","doi-asserted-by":"crossref","unstructured":"Hamik A and Peroutka SJ (1989) 1-(m-Chlorophenyl)piperazine (m CPP) interactions with neurotransmitter receptors in the human brain. Biol Psychiatry 25: 569-575.","DOI":"10.1016\/0006-3223(89)90217-5"},{"key":"10.1124\/jpet.106.113357_bib20","doi-asserted-by":"crossref","unstructured":"Huidobro-Toro JP, Valenzuela CF, and Harris RA (1996) Modulation of GABAA receptor function by G protein-coupled 5-HT2C receptors. Neuropharmacology 35: 1355-1363.","DOI":"10.1016\/S0028-3908(96)00084-6"},{"key":"10.1124\/jpet.106.113357_bib21","doi-asserted-by":"crossref","unstructured":"Houston GC, Papadakis NG, Carpenter TA, Hall LD, Mukherjee B, James MF, and Huang CL (2001) Mapping of brain activation in response to pharmacological agents using fMRI in the rat. Magn Reson Imaging 19: 905-919.","DOI":"10.1016\/S0730-725X(01)00405-2"},{"key":"10.1124\/jpet.106.113357_bib22","doi-asserted-by":"crossref","unstructured":"Ireland MD, Lowe AS, Reavill C, James MF, Leslie RA, and Williams SC (2005) Mapping the effects of the selective dopamine D2\/D3 receptor agonist quinelorane using pharmacological magnetic resonance imaging. Neuroscience 133: 315-326.","DOI":"10.1016\/j.neuroscience.2005.02.018"},{"key":"10.1124\/jpet.106.113357_bib23","doi-asserted-by":"crossref","unstructured":"Kahn RS and Wetzler S (1991) m-Chlorophenylpiperazine as a probe of serotonin function. Biol Psychiatry 30: 1139-1166.","DOI":"10.1016\/0006-3223(91)90184-N"},{"key":"10.1124\/jpet.106.113357_bib24","doi-asserted-by":"crossref","unstructured":"Kennett GA, Bailey F, Piper DC, and Blackburn TP (1995) Effect of SB 200646A, a 5-HT2C\/5-HT2B receptor antagonist, in two conflict models of anxiety. Psychopharmacology (Berl) 118: 178-182.","DOI":"10.1007\/BF02245837"},{"key":"10.1124\/jpet.106.113357_bib25","doi-asserted-by":"crossref","unstructured":"Kennett GA, Wood MD, Bright F, Trail B, Riley G, Holland V, Avenell KY, Stean T, Upton N, Bromidge S, et al. (1997) SB 242084, a selective and brain penetrant 5-HT2C receptor antagonist. Neuropharmacology 36: 609-620.","DOI":"10.1016\/S0028-3908(97)00038-5"},{"key":"10.1124\/jpet.106.113357_bib26","doi-asserted-by":"crossref","unstructured":"Knapp DJ, Overstreet DH, Moy SS, and Breese GR (2004) SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats. Alcohol 32: 101-111.","DOI":"10.1016\/j.alcohol.2003.08.007"},{"key":"10.1124\/jpet.106.113357_bib27","doi-asserted-by":"crossref","unstructured":"Lowy MT and Meltzer HY (1988) Stimulation of serum cortisol and prolactin secretion in humans by MK-212, a centrally active serotonin agonist. Biol Psychiatry 23: 818-828.","DOI":"10.1016\/0006-3223(88)90070-4"},{"key":"10.1124\/jpet.106.113357_bib28","doi-asserted-by":"crossref","unstructured":"Ori C, Dam M, Pizzolato G, Battistin L, and Giron G (1986) Effects of isoflurane anesthesia on local cerebral glucose utilization in the rat. Anesthesiology 65: 152-156.","DOI":"10.1097\/00000542-198608000-00004"},{"key":"10.1124\/jpet.106.113357_bib29","doi-asserted-by":"crossref","unstructured":"Overstreet DH, Knapp DJ, Moy SS, and Breese GR (2003) A 5-HT1A agonist and a 5-HT2C antagonist reduce social interaction deficit induced by multiple ethanol withdrawals in rats. Psychopharmacology (Berl) 167: 344-352.","DOI":"10.1007\/s00213-003-1425-y"},{"key":"10.1124\/jpet.106.113357_bib30","unstructured":"Paxinos G and Watson C (1982) The rat brain in stereotaxic co-ordinates. Academic Press, New York."},{"key":"10.1124\/jpet.106.113357_bib31","doi-asserted-by":"crossref","unstructured":"Rex A, Voigt JP, Gustedt C, Beckett S, and Fink H (2004) Anxiolytic-like profile in Wistar, but not Sprague-Dawley rats in the social interaction test. Psychopharmacology (Berl) 177: 23-34.","DOI":"10.1007\/s00213-004-1914-7"},{"key":"10.1124\/jpet.106.113357_bib32","unstructured":"Richards CD (1995) The synaptic basis of general anaesthesia. Eur J Anaesthesiol 12: 5-19."},{"key":"10.1124\/jpet.106.113357_bib33","doi-asserted-by":"crossref","unstructured":"Scanley BE, Kennan RP, and Gore JC (2001) Changes in rat cerebral blood volume due to modulation of the 5-HT(1A) receptor measured with susceptibility enhanced contrast MRI. Brain Res 913: 149-155.","DOI":"10.1016\/S0006-8993(01)02771-8"},{"key":"10.1124\/jpet.106.113357_bib34","doi-asserted-by":"crossref","unstructured":"Serrats J, Mengod G, and Cortes R (2005) Expression of serotonin 5-HT2C receptors in GABAergic cells of the anterior raphe nuclei. J Chem Neuroanat 29: 83-91.","DOI":"10.1016\/j.jchemneu.2004.03.010"},{"key":"10.1124\/jpet.106.113357_bib35","doi-asserted-by":"crossref","unstructured":"Short KR and Maier SF (1993) Stressor controllability, social interaction, and benzodiazepine systems. Pharmacol Biochem Behav 45: 827-835.","DOI":"10.1016\/0091-3057(93)90128-G"},{"key":"10.1124\/jpet.106.113357_bib36","doi-asserted-by":"crossref","unstructured":"Singewald N, Salchner P, and Sharp T (2003) Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs. Biol Psychiatry 53: 275-283.","DOI":"10.1016\/S0006-3223(02)01574-3"},{"key":"10.1124\/jpet.106.113357_bib37","doi-asserted-by":"crossref","unstructured":"Stark JA, Davies KE, Williams SR, and Luckman SM (2006) Functional magnetic resonance imaging and c-Fos mapping in rats following an anorectic dose of m-chlorophenylpiperazine. Neuroimage 31: 1228-1237.","DOI":"10.1016\/j.neuroimage.2006.01.046"},{"key":"10.1124\/jpet.106.113357_bib38","doi-asserted-by":"crossref","unstructured":"Steward CA, Marsden CA, Prior MJ, Morris PG, and Shah YB (2005) Methodological considerations in rat brain BOLD contrast pharmacological MRI. Psychopharmacology (Berl) 180: 687-704.","DOI":"10.1007\/s00213-005-2213-7"},{"key":"10.1124\/jpet.106.113357_bib39","doi-asserted-by":"crossref","unstructured":"Stutzmann JM, Eon B, Darche F, Lucas M, Rataud J, Piot O, Blanchard JC, and Laduron PM (1991) Are 5-HT2 antagonists endowed with anxiolytic properties in rodents? Neurosci Lett 128: 4-8.","DOI":"10.1016\/0304-3940(91)90747-H"},{"key":"10.1124\/jpet.106.113357_bib40","doi-asserted-by":"crossref","unstructured":"Varlinskaya EI and Spear LP (2002) Acute effects of ethanol on social behavior of adolescent and adult rats: role of familiarity of the test situation. Alcohol Clin Exp Res 26: 1502-1511.","DOI":"10.1111\/j.1530-0277.2002.tb02449.x"},{"key":"10.1124\/jpet.106.113357_bib41","doi-asserted-by":"crossref","unstructured":"Wood MD (2003) Therapeutic potential of 5-HT2C receptor antagonists in the treatment of anxiety disorders. Curr Drug Targets CNS Neurol Disord 2: 383-387.","DOI":"10.2174\/1568007033482698"},{"key":"10.1124\/jpet.106.113357_bib42","doi-asserted-by":"crossref","unstructured":"Wood MD, Reavill C, Trail B, Wilson A, Stean T, Kennett GA, Lightowler S, Blackburn TP, Thomas D, Gager TL, et al. (2001) SB-243213; a selective 5-HT2C receptor inverse agonist with improved anxiolytic profile: lack of tolerance and withdrawal anxiety. Neuropharmacology 41: 186-199.","DOI":"10.1016\/S0028-3908(01)00054-5"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524337255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524337255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.106.113357","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T22:11:10Z","timestamp":1740003070000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524337255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,3]]},"references-count":42,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,3]]}},"alternative-id":["S0022356524337255"],"URL":"https:\/\/doi.org\/10.1124\/jpet.106.113357","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2007,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5-Hydroxytryptamine2C Receptor Contribution to m-Chlorophenylpiperazine and N-Methyl-\u03b2-carboline-3-carboxamide-Induced Anxiety-Like Behavior and Limbic Brain Activation","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.106.113357","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2007 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}